FORBES-TATE

Lobbying for HALOZYME THERAPEUTICS, INC. · U.S. Biotechnology Company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $60,000.00 income · posted Oct 18, 2025

Lobbying activity 2

Health Issues

Issues related to biopharmaceutical research, development, and manufacturing.

Medicare/Medicaid

Issues related to coverage and reimbursement.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.